forms biofilms in acute infection independent of cell-to-cell signaling.
regulates flagellin expression as part of a global response to airway fluid from cystic fibrosis patients.
Mechanisms of action of Pseudomonas aeruginosa
Pyocyanin on human ciliary beat in-vitro.
In the present study, about 50% of the Pseudomonas species was Pseudomonas aeruginosa
followed by P.
Community-acquired Pseudomonas aeruginosa
pneumonia in a previously healthy young woman.
This in vitro study was designed to evaluate the impact of lactobacilli, nanoparticles and different commercial antibiotics on multiple drug resistant clinical isolates of Pseudomonas aeruginosa
obtained from patients in Lahore, Pakistan.
Differences of genetic diversity and antibiotics susceptibility of Pseudomonas aeruginosa
isolated from hospital, river and coastal seawater.
IMPs, VIMs and SPMs: the diversity of metallo-[beta]-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa
in a Brazilian hospital.
Colonization of patients at a long-term acute care hospital with Verona integron-encoded metallo-beta-lactamase-producing Pseudomonas aeruginosa
, timing of point prevalence surveys and implementation of infection control, and isolate pulsed-field gel electrophoresis (PFGE) results--Orange County, Florida, July-September, 2017
Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa
clinical isolate in France.
Goss, "Change in Pseudomonas aeruginosa
prevalence in cystic fibrosis adults over time," BMC Pulmonary Medicine, vol.
1 2 3 4 5 Staphylococcus aureus (MDR) - 250 500 250 - Escherichia coli (MDR) - 500 750 500 - Klebsiella species (MDR) - 1000 500 500 - Salmonella typhimurium (MDR) - 250 500 250 - Pseudomonas aeruginosa
(MDR) - 500 500 1000 - Escherichia coli ATCC-8739 500 250 500 750 250 Staphylococcus aureus ATCC-25923 250 250 125 125 125 Staphylococcus aureus 250 500 125 62.5 31.25 Escherichia coli - 250 500 1000 125 Klebsiella species 250 62.5 500 250 31.25 Pseudomonas aeruginosa
250 31.25 1500 125 500 Name of bacteria/compound no.